HER2-positive breast cancer treatment and survival rate

in breastcancer •  last year 

Human epidermal growth factor receptor 2 (HER2) is an overexpressed protein in certain types of breast cancer, including HER2-positive breast cancer. Surgery, chemotherapy, radiation therapy, and targeted therapy are frequently used to treat HER2-positive breast cancer. Trastuzumab (Herclon 440mg Injection), a medication that precisely targets the HER2 protein, is the primary targeted therapy for HER2-positive breast cancer. Pertuzumab (Perjeta) and ado-trastuzumab emtansine (Kadcyla) are other possible targeted therapeutics. HER2-positive breast cancer treatment and survival rate

breastcancer her2positive breast cancer
last year by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!